Loading
ליניאג תרפיוטיק is a listed company. Filings by its managers are published through TASE (ISA). From 18 October 2025 to 18 October 2026, the disclosure feed for ליניאג תרפיוטיק logged 11 filings by 11 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Across the 530 companies tracked on its exchange, the median is 14 filings; at 11 filings, this issuer sits below that mark.
Over the last twelve months, not one insider purchase of ליניאג תרפיוטיק stock was filed.
Source: insider filings from TASE (ISA). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
11 of 11 declarations
Linage Therapeutics is a company focused on developing regenerative therapies. It is listed on the XTAE market.